Anti-Müllerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells of small, growing follicles in the ovary. AMH serum concentrations decline over women’s reproductive lifespan, becoming undetectable approximately 5 years before menopause when the stock of primordial follicles is exhausted. Therefore, AMH has received increasing attention as a marker for ovarian reserves and has been shown to predict a woman’s reproductive potential.

AMH levels have become a useful fertility assessment tool that helps guide women’s fertility treatment and family planning decisions. AMH can also be used as a biomarker to diagnose polycystic ovary syndrome.
This report contains market size and forecasts of Anti-Müllerian Hormone Test Kit in global, including the following market information:
Global Anti-Müllerian Hormone Test Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti-Müllerian Hormone Test Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Müllerian Hormone Test Kit companies in 2021 (%)
The global Anti-Müllerian Hormone Test Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Use Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Müllerian Hormone Test Kit include Roche, Thermo Fisher Scientific, Eagle Biosciences, CTK Biotech, London Gynecology, Abbexa, LifeSpan BioSciences, Tecan and CUSABIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Müllerian Hormone Test Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Müllerian Hormone Test Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Müllerian Hormone Test Kit Market Segment Percentages, by Type, 2021 (%)
Human Use
Animal Use
Global Anti-Müllerian Hormone Test Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Müllerian Hormone Test Kit Market Segment Percentages, by Application, 2021 (%)
Household
Hospital & Clinic
Medical Laboratory
Others
Global Anti-Müllerian Hormone Test Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Müllerian Hormone Test Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Müllerian Hormone Test Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti-Müllerian Hormone Test Kit revenues share in global market, 2021 (%)
Key companies Anti-Müllerian Hormone Test Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti-Müllerian Hormone Test Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Thermo Fisher Scientific
Eagle Biosciences
CTK Biotech
London Gynecology
Abbexa
LifeSpan BioSciences
Tecan
CUSABIO
Zoomdoc
Bloom
myLAB Box
Hertility
CLOUD-CLONE
Global Diagnostics